Report Detail

According to our (Global Info Research) latest study, the global Radioactive Medical Isotopes market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Radioactive Medical Isotopes market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Radioactive Medical Isotopes market size and forecasts, in consumption value ($ Million), 2021-2032
Global Radioactive Medical Isotopes market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Radioactive Medical Isotopes market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Radioactive Medical Isotopes market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Radioactive Medical Isotopes
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Radioactive Medical Isotopes market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NRG, NTP Radioisotopes, JSC Isotope, ANSTO, China National Nuclear Corporation (CNNC), IRE ELIT, Nordion, Polatom, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Radioactive Medical Isotopes market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Carbon-14
Technetium-99m
Iodine-131
Iodine-125
Others
Market segment by Application
Diagnosis
Treatment
Others
Market segment by players, this report covers
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
China National Nuclear Corporation (CNNC)
IRE ELIT
Nordion
Polatom
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Radioactive Medical Isotopes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Radioactive Medical Isotopes, with revenue, gross margin, and global market share of Radioactive Medical Isotopes from 2021 to 2026.
Chapter 3, the Radioactive Medical Isotopes competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Radioactive Medical Isotopes market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radioactive Medical Isotopes.
Chapter 13, to describe Radioactive Medical Isotopes research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Radioactive Medical Isotopes by Type
    • 1.3.1 Overview: Global Radioactive Medical Isotopes Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Radioactive Medical Isotopes Consumption Value Market Share by Type in 2025
    • 1.3.3 Carbon-14
    • 1.3.4 Technetium-99m
    • 1.3.5 Iodine-131
    • 1.3.6 Iodine-125
    • 1.3.7 Others
  • 1.4 Global Radioactive Medical Isotopes Market by Application
    • 1.4.1 Overview: Global Radioactive Medical Isotopes Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Diagnosis
    • 1.4.3 Treatment
    • 1.4.4 Others
  • 1.5 Global Radioactive Medical Isotopes Market Size & Forecast
  • 1.6 Global Radioactive Medical Isotopes Market Size and Forecast by Region
    • 1.6.1 Global Radioactive Medical Isotopes Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Radioactive Medical Isotopes Market Size by Region, (2021-2032)
    • 1.6.3 North America Radioactive Medical Isotopes Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Radioactive Medical Isotopes Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Radioactive Medical Isotopes Market Size and Prospect (2021-2032)
    • 1.6.6 South America Radioactive Medical Isotopes Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Radioactive Medical Isotopes Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 NRG
    • 2.1.1 NRG Details
    • 2.1.2 NRG Major Business
    • 2.1.3 NRG Radioactive Medical Isotopes Product and Solutions
    • 2.1.4 NRG Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 NRG Recent Developments and Future Plans
  • 2.2 NTP Radioisotopes
    • 2.2.1 NTP Radioisotopes Details
    • 2.2.2 NTP Radioisotopes Major Business
    • 2.2.3 NTP Radioisotopes Radioactive Medical Isotopes Product and Solutions
    • 2.2.4 NTP Radioisotopes Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 NTP Radioisotopes Recent Developments and Future Plans
  • 2.3 JSC Isotope
    • 2.3.1 JSC Isotope Details
    • 2.3.2 JSC Isotope Major Business
    • 2.3.3 JSC Isotope Radioactive Medical Isotopes Product and Solutions
    • 2.3.4 JSC Isotope Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 JSC Isotope Recent Developments and Future Plans
  • 2.4 ANSTO
    • 2.4.1 ANSTO Details
    • 2.4.2 ANSTO Major Business
    • 2.4.3 ANSTO Radioactive Medical Isotopes Product and Solutions
    • 2.4.4 ANSTO Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 ANSTO Recent Developments and Future Plans
  • 2.5 China National Nuclear Corporation (CNNC)
    • 2.5.1 China National Nuclear Corporation (CNNC) Details
    • 2.5.2 China National Nuclear Corporation (CNNC) Major Business
    • 2.5.3 China National Nuclear Corporation (CNNC) Radioactive Medical Isotopes Product and Solutions
    • 2.5.4 China National Nuclear Corporation (CNNC) Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 China National Nuclear Corporation (CNNC) Recent Developments and Future Plans
  • 2.6 IRE ELIT
    • 2.6.1 IRE ELIT Details
    • 2.6.2 IRE ELIT Major Business
    • 2.6.3 IRE ELIT Radioactive Medical Isotopes Product and Solutions
    • 2.6.4 IRE ELIT Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 IRE ELIT Recent Developments and Future Plans
  • 2.7 Nordion
    • 2.7.1 Nordion Details
    • 2.7.2 Nordion Major Business
    • 2.7.3 Nordion Radioactive Medical Isotopes Product and Solutions
    • 2.7.4 Nordion Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Nordion Recent Developments and Future Plans
  • 2.8 Polatom
    • 2.8.1 Polatom Details
    • 2.8.2 Polatom Major Business
    • 2.8.3 Polatom Radioactive Medical Isotopes Product and Solutions
    • 2.8.4 Polatom Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Polatom Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Radioactive Medical Isotopes Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Radioactive Medical Isotopes by Company Revenue
    • 3.2.2 Top 3 Radioactive Medical Isotopes Players Market Share in 2025
    • 3.2.3 Top 6 Radioactive Medical Isotopes Players Market Share in 2025
  • 3.3 Radioactive Medical Isotopes Market: Overall Company Footprint Analysis
    • 3.3.1 Radioactive Medical Isotopes Market: Region Footprint
    • 3.3.2 Radioactive Medical Isotopes Market: Company Product Type Footprint
    • 3.3.3 Radioactive Medical Isotopes Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Radioactive Medical Isotopes Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Radioactive Medical Isotopes Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Radioactive Medical Isotopes Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Radioactive Medical Isotopes Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Radioactive Medical Isotopes Consumption Value by Type (2021-2032)
  • 6.2 North America Radioactive Medical Isotopes Market Size by Application (2021-2032)
  • 6.3 North America Radioactive Medical Isotopes Market Size by Country
    • 6.3.1 North America Radioactive Medical Isotopes Consumption Value by Country (2021-2032)
    • 6.3.2 United States Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Radioactive Medical Isotopes Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Radioactive Medical Isotopes Consumption Value by Type (2021-2032)
  • 7.2 Europe Radioactive Medical Isotopes Consumption Value by Application (2021-2032)
  • 7.3 Europe Radioactive Medical Isotopes Market Size by Country
    • 7.3.1 Europe Radioactive Medical Isotopes Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 7.3.3 France Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Radioactive Medical Isotopes Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Radioactive Medical Isotopes Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Radioactive Medical Isotopes Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Radioactive Medical Isotopes Market Size by Region
    • 8.3.1 Asia-Pacific Radioactive Medical Isotopes Consumption Value by Region (2021-2032)
    • 8.3.2 China Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 8.3.5 India Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Radioactive Medical Isotopes Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Radioactive Medical Isotopes Consumption Value by Type (2021-2032)
  • 9.2 South America Radioactive Medical Isotopes Consumption Value by Application (2021-2032)
  • 9.3 South America Radioactive Medical Isotopes Market Size by Country
    • 9.3.1 South America Radioactive Medical Isotopes Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Radioactive Medical Isotopes Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Radioactive Medical Isotopes Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Radioactive Medical Isotopes Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Radioactive Medical Isotopes Market Size by Country
    • 10.3.1 Middle East & Africa Radioactive Medical Isotopes Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Radioactive Medical Isotopes Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Radioactive Medical Isotopes Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Radioactive Medical Isotopes Market Drivers
  • 11.2 Radioactive Medical Isotopes Market Restraints
  • 11.3 Radioactive Medical Isotopes Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Radioactive Medical Isotopes Industry Chain
  • 12.2 Radioactive Medical Isotopes Upstream Analysis
  • 12.3 Radioactive Medical Isotopes Midstream Analysis
  • 12.4 Radioactive Medical Isotopes Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Radioactive Medical Isotopes. Industry analysis & Market Report on Radioactive Medical Isotopes is a syndicated market report, published as Global Radioactive Medical Isotopes Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Radioactive Medical Isotopes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report